Valeant to Buy Medicis Pharmaceutical For $2.6B

Valeant Pharmaceuticals International, Inc. said it agreed to buy Medicis Pharmaceutical Corp. in a transaction valued at about $2.6 billion.
Can Anyone Turn Abercrombie & Fitch Around?
18:10 - March 4 -- Story Founder and CEO Rachel Schechtman and Former Bloomingdales CEO and Chairman Michael Gould discuss Abercrombie & Fitch. Bloomberg’s Lindsey Rupp also speaks on “Market Makers.”
  • Are Abercrombie & Fitch’s Go-Go Days Over?
  • The Man Who Invented the Reebok Pump
  • Service Industries Post Unexpected Increase